HOPKINTON, Mass.–(BUSINESS WIRE)–Keensight Capital (“Keensight”), one of the leading private equity managers dedicated to pan-European Growth Buyout[1] investments, today announced it has agreed to acquire a majority stake in Isto Biologics (“Isto”) from Thompson Street Capital Partners (“TSCP”). TSCP will retain a minority stake, alongside Isto Biologics’ management team. Founded in 2016, Isto Biologics is a regenerative MedTech company developing and manufacturing orthobiologic products to